Rickettsia bellii is a rickettsial species of unknown pathogenicity that infects argasid and ixodid ticks throughout the Americas. Many molecular assays used to detect spotted fever group (SFG) Rickettsia species do not detect R. bellii, so that infection with this bacterium may be concealed in tick populations when assays are used that screen specifically for SFG rickettsiae. We describe the development and validation of a R. bellii-specific, quantitative, real-time PCR TaqMan assay that targets a segment of the citrate synthase (gltA) gene. The specificity of this assay was validated against a panel of DNA samples that included 26 species of Rickettsia, Orientia, Ehrlichia, Anaplasma, and Bartonella, five samples of tick and human DNA, and DNA from 20 isolates of R. bellii, including 11 from North America and nine from South America. A R. bellii control plasmid was constructed, and serial dilutions of the plasmid were used to determine the limit of detection of the assay to be one copy per 4 ml of template DNA. This assay can be used to better determine the role of R. bellii in the epidemiology of tickborne rickettsioses in the Western Hemisphere.
First isolated in 1966 from a pool of Dermacentor variabilis ticks collected near Fayetteville, AR, Rickettsia bellii is an obligate intracellular, Gram-negative coccobacillus of unknown pathogenicity. R. bellii has been found in tick populations throughout the Western Hemisphere where it infects both argasid and ixodid ticks including Argas, Amblyomma, Dermacentor, Haemaphysalis, Ixodes, and Ornithodoros species (Philip et al. 1983 , Horta et al. 2006 , Labruna et al. 2007b , Miranda and Mattar 2014 . While R. bellii is not known to be pathogenic to humans, it might play a role in the maintenance and distribution of other pathogenic tick-borne Rickettsia species. For example, in Amblyomma dubitatum ticks, a primary R. bellii infection has been shown to markedly diminish the transovarial transmission of R. rickettsii when secondarily infected with this pathogenic SFG Rickettsia species (Sakai et al. 2014) . Considering the wide variety and collectively expansive range of tick species that are infected with R. bellii, inhibition of transovarial transmission resulting from a primary R. bellii infection could play an important role in the ecology of several pathogenic rickettsial species.
Many contemporary surveys for Rickettsia species in ticks have relied primarily or exclusively on assays that target the rickettsial outer membrane protein A (ompA) gene (Moncayo et al. 2010 , Fritzen et al. 2011 , Stromdahl et al. 2011 , Venzal et al. 2012 , Goddard et al. 2014 , Henning et al. 2014 , Trout Fryxell et al. 2015 . Because R. bellii lacks this gene (Ogata et al. 2006) , ompAbased PCR assays will not detect R. bellii. As previous culture-based assessments have identified infection rates as high as 80% in some tick populations (Philip et al. 1983) , it is possible that many current molecular surveys underestimate the prevalence of this Rickettsia. A R. bellii-specific assay would be instrumental in determining whether or not the prevalence of R. bellii has truly fallen, or if the decrease in prevalence is a result of the limitations of the assays being used to screen for SFG Rickettsia.
We describe the development and validation of a R. bellii-specific real-time TaqMan assay that targets a 338-bp segment of the R. bellii gltA gene, using previously published primers (Szab o et al. 2013 ) and a novel probe. With the addition of a specific probe, this assay provides a highly sensitive and quantitative assay for detecting R. bellii.
Materials and Methods
Primer Verification et al. 2013). Using R. bellii DNA, we determined the optimal cycling conditions for these primers to be a 5 min melt at 95 C, followed by 35 cycles of 30 s at 95 C, 30 s at 52 C, and 1 min at 72 C, followed by a final extension step of 10 min at 72 C. Primer specificity was tested against a panel of 51 different DNA samples; 31 samples of various Rickettsia, Orientia, Ehrlichia, Anaplasma, Bartonella species, several tick species, human cells, and several other bacterial species (Table 1) . Primer sensitivity was evaluated against a panel of DNA samples extracted from 20 distinct R. bellii isolates from North and South America (Table 2) . Each reaction consisted of 10 ml Taq PCR Master Mix (QIAGEN, Valencia, CA), 1 mM each of the forward and reverse primers, 2 ml of template DNA and PCR-grade water to bring the final volume to 20 ml. All PCR reactions were run in an Eppendorf Mastercycler nexus gradient thermal cycler (Eppendorf AG, Hamburg, Germany) and the amplified PCR products were visualized by UV lamp in a 1.5% agarose gel containing 0.1 mg/ml ethidium bromide. Positive control DNA and no template control samples were included with each set of reactions.
Probe Design
The gltA gene sequences from eight different strains of R. bellii were aligned with the primer set and the gltA gene sequences of other rickettsial species (Fig. 1 ) using MEGA version 6 software (Tamura et al. 2013) to identify areas within the 338-bp target region that differed among R. bellii and the other ricketsial species. A 26-bp FAM-labeled probe was designed (5 0 FAM-ATGATGTTTGCCACACCTTGTGAAAA-BHQ1-3 0 ) that is identical to all of the R. bellii sequences in the alignment.
Real-Time PCR Optimization
All real-time PCR reactions were run in a BioRad CFX 96 thermal cycler using the QuantiTect Multiplex PCR Kit (QIAGEN, Valencia, CA). Each reaction consisted of 12.5 ml Quantitect Multiplex PCR Master Mix, 0.2 mM of the forward and reverse primers as well as the probe, 4 ml of template DNA, and PCR grade water to bring the final volume to 25 ml. Samples were run in duplicate, with positive control DNA and no template control samples added to every plate. The efficacy of the probe was tested using three different R. bellii samples. Gradient PCR was used to determine the optimal cycling conditions of 15 min at 95 C followed by 45 cycles of 30 s at 93 C, 30 s at 57 C, and 1 min at 72 C. This was followed by a final extension step of 10 min at 72 C. Fluorescence data were collected at the end of the annealing step of every cycle.
Cloning and Sequencing
A control plasmid was constructed by ligating the 338-bp R. bellii amplicon into pCR2.1 using the TOPO TA cloning kit (Life Technologies, Grand Island, NY). The integrity of the insertion site and the sequence of the R. bellii fragment were verified via PCR and DNA sequencing using primers M13 reverse and T7 promoter. The plasmid was subsequently used to determine the limit of detection of the assay and as a positive control for the real-time assay. As the purified plasmid may contain a small amount of Escherichia coli DNA carried over from the competent cells used to replicate the plasmid, the assay was tested to ensure that it would not amplify E. coli DNA.
Specificity and Sensitivity of Real-time Assay
To determine the limit of detection of the assay, the concentration of the R. bellii gltA control plasmid was ascertained using a Qubit 2.0 fluorometer (Life Technologies) and serial dilutions of 10 5 , 10 4 , 10 3 , 10 2 , 10, 5, 2.5, and 1 copy number per 4 ml of DNA were used as template DNA. The specificity of the combined primer-probe set was evaluated using the same panel of 51 DNA samples previously (Tables 1 and 2 ) in order to verify that the addition of the probe did not result in nonspecific binding.
Results and Discussion
A dilution series was run in duplicate to determine the limit of detection of the assay to be 1 copy number per 4 ml of DNA, with an R 2 value of the standard curve for the dilution series of 0.993, establishing the cutoff for positive samples at 40 cycles for future screenings. All 31 of the non-R. bellii DNA samples used to assess assay specificity were negative using the TaqMan assay. Additionally, each of the 20 R. bellii DNA samples, obtained from nine different tick species collected from North and South America, were positive by this assay. This panel of 20 R. bellii isolates represents a geographically and genetically (F.S.K., unpublished data) diverse group, which demonstrates that this assay provides a sensitive technique to detect R. bellii. Application of this assay may facilitate efforts to better understand the role of R. bellii in the ecology and epidemiology of tick-borne rickettsioses in the Western Hemisphere.
